Citations per year, relative to Abraham Goldin Abraham Goldin (= 1×)
peers
Howard E. Skipper
Countries citing papers authored by Abraham Goldin
Since
Specialization
Citations
This map shows the geographic impact of Abraham Goldin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abraham Goldin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abraham Goldin more than expected).
This network shows the impact of papers produced by Abraham Goldin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abraham Goldin. The network helps show where Abraham Goldin may publish in the future.
Co-authorship network of co-authors of Abraham Goldin
This figure shows the co-authorship network connecting the top 25 collaborators of Abraham Goldin.
A scholar is included among the top collaborators of Abraham Goldin based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Abraham Goldin. Abraham Goldin is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Mantel, Nathan, et al.. (1972). The effect of the sequence of administration of cytoxan and methotrexate on the life-span of L1210 leukemic mice.. PubMed. 32(2). 200–7.5 indexed citations
Goldin, Abraham. (1969). Summary of the General Discussion Session. Cancer Research. 29(12). 2427–2434.1 indexed citations
11.
Chirigos, Michael A., Frank J. Rauscher, Ismail A. Kamel, G R Fanning, & Abraham Goldin. (1963). STUDIES WITH THE MURINE LEUKEMOGENIC RAUSCHER VIRUS. II. CHEMOTHERAPY OF VIRUS-INDUCED LYMPHOID LEUKEMIA.. PubMed. 23. 1646–50.9 indexed citations
12.
Chirigos, Michael A., Frank J. Rauscher, Ismail A. Kamel, G R Fanning, & Abraham Goldin. (1963). Studies with the murine leukemogenic Rauscher virus. I. Chemotherapy studies with in vivo and in vitro assay systems.. PubMed. 23. 762–9.17 indexed citations
13.
Venditti, John M., Anthony W. Schrecker, J. A. R. Mead, I Kline, & Abraham Goldin. (1960). Influence of the route of administration on the relative effectiveness of 3',5'-dichloroamethopterin and amethopterin against advanced leukemia (L1210) in mice.. PubMed. 20. 1451–6.6 indexed citations
14.
Schrecker, Anthony W., et al.. (1960). Effect of orally administered 3', 5'-dichloroamethopterin on formate-C14 incorporation in leukemic mice.. PubMed. 20. 1457–61.3 indexed citations
Venditti, John M., Stewart R. Humphreys, Nathan Mantel, & Abraham Goldin. (1957). Influence of the duration of treatment with A-methopterin on the survival time of mice with advanced leukemia (L1210).. PubMed. 17(9). 917–22.4 indexed citations
18.
Humphreys, Stewart R., John M. Venditti, Nathan Mantel, & Abraham Goldin. (1956). Observations on a Leukemic Cell Variant in Mice. JNCI Journal of the National Cancer Institute. 17(4). 447–57.5 indexed citations
Goldin, Abraham, Nathan Mantel, Samuel W. Greenhouse, John M. Venditti, & Stewart R. Humphreys. (1953). Estimation of the antileukemic potency of the antimetabolite aminopterin, administered alone and in combination with citrovorum factor or folic acid.. PubMed. 13(12). 843–50.42 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.